Michael R Lewis Selected Research

Michael R Lewis Research Topics

Disease

34	Neoplasms (Cancer) 01/2021 - 08/2002
7	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2018
7	Prediabetic State (Prediabetes) 01/2022 - 01/2018
5	Lymphoma (Lymphomas) 11/2015 - 11/2003
4	B-Cell Lymphoma (Lymphoma, B Cell) 11/2015 - 11/2003
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2021 - 04/2017
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 08/2003
3	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 07/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2003
2	Polyps 01/2021 - 01/2018
2	Hypersensitivity (Allergy) 01/2016 - 01/2005
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2015 - 03/2015
2	Leukemia 01/2014 - 11/2003
2	Colonic Neoplasms (Colon Cancer) 12/2011 - 11/2005
2	Carcinoma (Carcinomatosis) 06/2011 - 03/2006
2	Osteosarcoma (Osteogenic Sarcoma) 02/2008 - 12/2005
1	Obesity 01/2021
1	Overweight 01/2021
1	Heart Failure 01/2019
1	Adenoma (Adenomas) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Kidney Diseases (Kidney Disease) 07/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2017
1	Sickle Cell Trait 07/2017
1	Stroke (Strokes) 07/2017
1	Infections 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 02/2015
1	Pancytopenia 05/2014
1	B-Cell Leukemia (Leukemia, B Cell) 05/2012
1	Carcinogenesis 11/2009
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2008
1	Adenocarcinoma 05/2007
1	Disease Progression 11/2003

Drug/Important Bio-Agent (IBA)

14	Peptides (Polypeptides)IBA 03/2021 - 11/2003
7	Vitamin D FDA LinkGeneric 01/2022 - 01/2018
6	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2021 - 10/2003
6	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 11/2015 - 03/2006
5	Glucose (Dextrose)FDA LinkGeneric 06/2020 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 09/2015 - 02/2002
5	Radioisotopes (Radionuclides)IBA 03/2015 - 08/2003
5	Monoclonal AntibodiesIBA 12/2011 - 08/2003
4	RadiopharmaceuticalsIBA 01/2018 - 08/2002
4	Messenger RNA (mRNA)IBA 11/2015 - 11/2002
4	StreptavidinIBA 12/2011 - 08/2003
3	Hemoglobins (Hemoglobin)IBA 01/2020 - 07/2017
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2009
3	IntegrinsIBA 01/2018 - 02/2015
3	LigandsIBA 04/2017 - 07/2007
3	Copper-64IBA 04/2016 - 10/2003
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2016 - 10/2003
3	Chelating AgentsIBA 03/2015 - 11/2003
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020 - 01/2019
2	Bombesin Receptors (Bombesin Receptor)IBA 01/2018 - 02/2015
2	Tyr(3)- octreotateIBA 11/2015 - 01/2014
2	Immunoconjugates (Immunoconjugate)IBA 03/2015 - 11/2005
2	Peptide Nucleic AcidsIBA 05/2012 - 11/2003
2	AcidsIBA 06/2011 - 10/2003
2	Octreotide (Sandostatin)FDA LinkGeneric 07/2010 - 10/2003
2	samarium Sm-153 lexidronam (Quadramet)FDA Link 02/2008 - 12/2005
2	Organophosphonates (Phosphonates)IBA 02/2008 - 12/2005
1	hydroxide ionIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	MetalsIBA 03/2021
1	beta-microseminoproteinIBA 01/2021
1	25-hydroxyvitamin DIBA 01/2019
1	Cholecalciferol (Vitamin D3)FDA Link 01/2019
1	TroponinIBA 01/2018
1	Insulin (Novolin)FDA Link 01/2018
1	AntigensIBA 01/2018
1	Testosterone (Sustanon)FDA Link 01/2018
1	LipidsIBA 01/2018
1	CholesterolIBA 01/2018
1	Hemoglobin CIBA 07/2017
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2016
1	Transferrin (beta 2 Transferrin)IBA 01/2016
1	VaccinesIBA 01/2016
1	Amino Acids FDA Link 11/2015
1	CopperIBA 11/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2015
1	tyrosyl-lysineIBA 03/2015
1	arginyl-glycyl-aspartic acidIBA 03/2015
1	BombesinIBA 02/2015
1	Indicators and Reagents (Reagents)IBA 05/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2012
1	thiamine triphosphorate (TTP)IBA 05/2012
1	Biotin (Vitamin H)FDA Link 12/2011
1	Acetic Acid (Vinegar)FDA LinkGeneric 10/2011
1	AntibodiesIBA 06/2011
1	Arsenazo IIIIBA 11/2008
1	Carcinoembryonic AntigenIBA 10/2007
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 07/2007
1	Biological ProductsIBA 03/2006
1	Codon (Codons)IBA 11/2003
1	DTPA folateIBA 10/2003

Therapy/Procedure

13	Therapeutics 01/2018 - 08/2003
8	Radiotherapy 01/2018 - 11/2002
7	Radioimmunotherapy 03/2015 - 08/2003
2	Drug Therapy (Chemotherapy) 05/2014 - 11/2003
1	Intravenous Injections 02/2015
1	Ovariectomy (Oophorectomy) 05/2007